These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Alterations in the binding of the phosphodiesterase inhibitor, rolipram, after transient ischemia in the gerbil brain. Asanuma M; Ogawa N; Hirata H; Kondo Y; Nishibayashi S; Yamamoto M; Mori A Res Commun Chem Pathol Pharmacol; 1993 Dec; 82(3):279-85. PubMed ID: 8122028 [TBL] [Abstract][Full Text] [Related]
23. Modulation of spasmogen-stimulated Ins(1,4,5)P3 generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle. Challiss RA; Adams D; Mistry R; Nicholson CD Br J Pharmacol; 1998 May; 124(1):47-54. PubMed ID: 9630342 [TBL] [Abstract][Full Text] [Related]
24. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine. Katano Y; Endoh M J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732 [TBL] [Abstract][Full Text] [Related]
25. Congenital nephrogenic diabetes insipidus with bilateral hydronephrosis: indomethacin in treatment of nephrogenic diabetes insipidus. Sohn YM; Lee C; Kim PK; Yun DJ Yonsei Med J; 1980; 21(2):116-22. PubMed ID: 7314648 [No Abstract] [Full Text] [Related]
26. Diabetes Insipidus. Lu HA Adv Exp Med Biol; 2017; 969():213-225. PubMed ID: 28258576 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes. Villagrasa V; Navarrete C; Sanz C; Berto L; Perpiñá M; Cortijo J; Morcillo EJ Methods Find Exp Clin Pharmacol; 1996 May; 18(4):239-45. PubMed ID: 8803956 [TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase inhibitors may be indicated in the treatment of postulated vasoactive neuropeptide autoimmune fatigue-related disorders. Staines DR Med Hypotheses; 2006; 66(1):203-4. PubMed ID: 16171950 [No Abstract] [Full Text] [Related]
33. Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea-pigs and airway leukocyte infiltration. Danahay H; Broadley KJ Br J Pharmacol; 1997 Jan; 120(2):289-97. PubMed ID: 9117122 [TBL] [Abstract][Full Text] [Related]
34. Is phosphodiesterase inhibition a new mechanism of antidepressant action? A double blind double-dummy study between rolipram and desipramine in hospitalized major and/or endogenous depressives. Bobon D; Breulet M; Gerard-Vandenhove MA; Guiot-Goffioul F; Plomteux G; Sastre-y-Hernández M; Schratzer M; Troisfontaines B; von Frenckell R; Wachtel H Eur Arch Psychiatry Neurol Sci; 1988; 238(1):2-6. PubMed ID: 3063534 [TBL] [Abstract][Full Text] [Related]
35. PGE1 and prostacyclin suppression of NK-cell mediated cytotoxicity and its relation to cyclic AMP. Lanefelt F; Ullberg M; Jondal M; Fredholm BB Med Biol; 1983; 61(6):324-30. PubMed ID: 6328136 [TBL] [Abstract][Full Text] [Related]
36. Effects of rolipram and cilostamide on renal functions and cyclic AMP release in anesthetized dogs. Tanahashi M; Hara S; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S J Pharmacol Exp Ther; 1999 Jun; 289(3):1533-8. PubMed ID: 10336549 [TBL] [Abstract][Full Text] [Related]
37. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation. Ransjö M; Fredholm BB; Lerner UH Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948 [TBL] [Abstract][Full Text] [Related]